Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study*
Kathy Petoumenos(UNSW Sydney), Wafaa El‐Sadr(Columbia University Irving Medical Center), Ole Kirk(University of Copenhagen), Nina Friis‐Møller(University of Copenhagen), Signe Westring Worm(University of Copenhagen), Christian Pradier(Université Côte d'Azur), Rainer Weber(Georg Simon Ohm University of Applied Sciences Nuremberg), Antonella d’Arminio Monforte(University of Milan), Matthew Law(UNSW Sydney), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Caroline Sabin(Primary Health Care), P. Mercié(Centre National de la Recherche Scientifique), Peter Reiss(Amsterdam Institute for Global Health and Development), Stéphane De Wit(Centre Hospitalier Universitaire de Saint-Pierre)
Cited by 189
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
|The Journal of Infectious Diseases|2011|1.1k